CBSC
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Capitalization
5.46M
Intraday BUY SELL Signals
CHEOF
Price
$174.02
Change
-$12.42 (-6.66%)
Updated
Jan 14 closing price
Capitalization
11.66B
Intraday BUY SELL Signals
Interact to see
Advertisement

CBSC vs CHEOF

Header iconCBSC vs CHEOF Comparison
Open Charts CBSC vs CHEOFBanner chart's image
Cardiac Biotech Solutions
Price$0.03
Change-$0.00 (-0.00%)
Volume$22.15K
Capitalization5.46M
CochLear
Price$174.02
Change-$12.42 (-6.66%)
Volume$2
Capitalization11.66B
CBSC vs CHEOF Comparison Chart in %
CBSC
Daily Signal:
Gain/Loss:
CHEOF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CBSC vs. CHEOF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBSC is a Hold and CHEOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CBSC: $0.03 vs. CHEOF: $174.02)
Brand notoriety: CBSC and CHEOF are both not notable
CBSC represents the Pharmaceuticals: Other, while CHEOF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CBSC: 61% vs. CHEOF: 3%
Market capitalization -- CBSC: $5.46M vs. CHEOF: $11.66B
CBSC [@Pharmaceuticals: Other] is valued at $5.46M. CHEOF’s [@Medical/Nursing Services] market capitalization is $11.66B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.82B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.1B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBSC’s FA Score shows that 1 FA rating(s) are green whileCHEOF’s FA Score has 1 green FA rating(s).

  • CBSC’s FA Score: 1 green, 4 red.
  • CHEOF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHEOF is a better buy in the long-term than CBSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBSC’s TA Score shows that 4 TA indicator(s) are bullish while CHEOF’s TA Score has 1 bullish TA indicator(s).

  • CBSC’s TA Score: 4 bullish, 7 bearish.
  • CHEOF’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, CBSC is a better buy in the short-term than CHEOF.

Price Growth

CBSC (@Pharmaceuticals: Other) experienced а -17.03% price change this week, while CHEOF (@Medical/Nursing Services) price change was +2.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.83%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was -0.06%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.17%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +23.73%.

Industries' Descriptions

@Pharmaceuticals: Other (-0.83% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+4.17% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHEOF($11.7B) has a higher market cap than CBSC($5.46M). CHEOF YTD gains are higher at: 3.242 vs. CBSC (-16.981). CHEOF has higher annual earnings (EBITDA): 620M vs. CBSC (-1.53M). CHEOF has more cash in the bank: 276M vs. CBSC (22K). CBSC has less debt than CHEOF: CBSC (358K) vs CHEOF (236M). CHEOF has higher revenues than CBSC: CHEOF (2.34B) vs CBSC (74.9K).
CBSCCHEOFCBSC / CHEOF
Capitalization5.46M11.7B0%
EBITDA-1.53M620M-0%
Gain YTD-16.9813.242-524%
P/E RatioN/A43.82-
Revenue74.9K2.34B0%
Total Cash22K276M0%
Total Debt358K236M0%
FUNDAMENTALS RATINGS
CBSC vs CHEOF: Fundamental Ratings
CBSC
CHEOF
OUTLOOK RATING
1..100
7330
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
10045
PRICE GROWTH RATING
1..100
6356
P/E GROWTH RATING
1..100
475
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEOF's Valuation (15) in the null industry is significantly better than the same rating for CBSC (100). This means that CHEOF’s stock grew significantly faster than CBSC’s over the last 12 months.

CHEOF's Profit vs Risk Rating (86) in the null industry is in the same range as CBSC (100). This means that CHEOF’s stock grew similarly to CBSC’s over the last 12 months.

CHEOF's SMR Rating (45) in the null industry is somewhat better than the same rating for CBSC (100). This means that CHEOF’s stock grew somewhat faster than CBSC’s over the last 12 months.

CHEOF's Price Growth Rating (56) in the null industry is in the same range as CBSC (63). This means that CHEOF’s stock grew similarly to CBSC’s over the last 12 months.

CBSC's P/E Growth Rating (4) in the null industry is significantly better than the same rating for CHEOF (75). This means that CBSC’s stock grew significantly faster than CHEOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBSCCHEOF
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 14 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
CBSC
Daily Signal:
Gain/Loss:
CHEOF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLYD6.080.26
+4.47%
MicroSectors™ Travel -3X Inv Lvgd ETNs
DSTL60.550.39
+0.65%
Distillate US Fdmtl Stblty & Val ETF
IBIC25.590.01
+0.04%
iShares iBonds Oct 2026 Term Tips ETF
RSST30.08N/A
N/A
Return Stacked® US Stocks & Mgd Futs ETF
QQA53.44-0.40
-0.74%
Invesco QQQ Income Advantage ETF

CBSC and

Correlation & Price change

A.I.dvisor tells us that CBSC and LNSR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBSC and LNSR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSC
1D Price
Change %
CBSC100%
+4.43%
LNSR - CBSC
20%
Poorly correlated
+1.19%
CALZF - CBSC
6%
Poorly correlated
N/A
BBLG - CBSC
3%
Poorly correlated
-1.23%
BLOZF - CBSC
3%
Poorly correlated
+1.25%
CHEOF - CBSC
1%
Poorly correlated
-6.66%
More

CHEOF and

Correlation & Price change

A.I.dvisor tells us that CHEOF and FSPKF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEOF and FSPKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEOF
1D Price
Change %
CHEOF100%
-6.66%
FSPKF - CHEOF
21%
Poorly correlated
N/A
A - CHEOF
20%
Poorly correlated
-0.27%
CHEOY - CHEOF
15%
Poorly correlated
+0.89%
BMXMF - CHEOF
11%
Poorly correlated
-7.75%
CALZF - CHEOF
11%
Poorly correlated
N/A
More